What question did this study set out to answer?

The central aim is to explore innovations in cardio-oncology as a response to the challenges posed by the COVID-19 pandemic.

synapse

⌘+K

August 14, 2020Open Access

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World

Q: What is the clinical evidence from this study?

Study design: Other. Population: cardio-oncology. Intervention: digital health technologies vs. traditional care without digital health. Primary outcome: Improvement in patient outcomes through remote monitoring and telemedicine.

Key Result

Digital health technologies, including telemedicine and mobile health, have the potential to significantly improve care for cardio-oncology patients during and after the COVID-19 pandemic by enabling remote monitoring and timely interventions.

Key Points

The central aim is to explore innovations in cardio-oncology as a response to the challenges posed by the COVID-19 pandemic.
Analyzed recent advancements and adaptations in cardio-oncology treatment.
Examined the impact of telehealth and digital tools on patient care.
Discussed the necessity of integrating precision medicine for personalized treatment.
Significant adoption of telehealth solutions improved patient access to cardio-oncology care.
Experts emphasize the importance of biomarkers in tailoring personalized treatment strategies.
Future developments in cardio-oncology are expected to enhance patient outcomes and management.

PICO

Population

cardio-oncology

Intervention / Comparator

digital health technologies vs traditional care without digital health

Primary Outcome

Improvement in patient outcomes through remote monitoring and telemedicine

Abstract

OPINION article Front. Cardiovasc. Med., 14 August 2020Sec. Cardio-Oncology Volume 7 - 2020 | https://doi.org/10.3389/fcvm.2020.00145

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Brown et al. (Fri,) conducted a other in cardio-oncology. digital health technologies vs. traditional care without digital health was evaluated on Improvement in patient outcomes through remote monitoring and telemedicine. Digital health technologies, including telemedicine and mobile health, have the potential to significantly improve care for cardio-oncology patients during and after the COVID-19 pandemic by enabling remote monitoring and timely interventions.

synapsesocial.com/papers/69713eb569d8408cd81c25f9 https://doi.org/https://doi.org/10.3389/fcvm.2020.00145

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: